ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 83459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 83459; 2) Community: the network communities that were significantly associated with the response to NSC 83459; 3) Molecule: the relationships between components within communities and NSC 83459; 4) MDR: the compounds that were significantly associated with the NSC 83459.

NSC Compound Enrichment Correlation
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0126882509540134 0.21583304
NSC 114346 Null 0.0126882509540134 0.22792816
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0126882509540134 0.51568373
NSC 18805 .gamma.-Thujaplicine 0.0126882509540134 0.38483862
NSC 300289 Pinafide 0.0126882509540134 0.22765066
NSC 303812 Aphidicoline glycinate 0.0126882509540134 0.3681344
NSC 33570 Null 0.0126882509540134 0.29118785
NSC 339137 PHYSALOLACTONE 0.0126882509540134 0.24588951
NSC 349622 Cytovaricin 0.0126882509540134 0.27654125
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0126882509540134 0.14650115
Total:134  Current:38    [First] [Prev] [Next] [Last]